Concepedia

P1.01-81 Phase 3 Study of Pemetrexed-Platinum with or without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789

Greg J. Riely, Rina Hui, David P. Carbone, K. Park, Marion Carrigan, X. Xu, T. Dang, James Chih‐Hsin Yang

Journal of Thoracic Oncology · 2018 · 23 citations · 0 references

Concepts

Tki-resistant/egfr-mutated Advanced NsclcMedicineImmunologyPathologyImmune Checkpoint InhibitorCancer TreatmentP1.01-81 Phase 3OncologyRadiation OncologyNovel TherapyMolecular Oncology